179 related articles for article (PubMed ID: 23217400)
41. Smoking affects eotaxin levels in asthma patients.
Krisiukeniene A; Babusyte A; Stravinskaite K; Lotvall J; Sakalauskas R; Sitkauskiene B
J Asthma; 2009 Jun; 46(5):470-6. PubMed ID: 19544167
[TBL] [Abstract][Full Text] [Related]
42. The expression of Foxp3 and ROR gamma t in lung tissues from normal smokers and chronic obstructive pulmonary disease patients.
Chu S; Zhong X; Zhang J; Lao Q; He Z; Bai J
Int Immunopharmacol; 2011 Nov; 11(11):1780-8. PubMed ID: 21791252
[TBL] [Abstract][Full Text] [Related]
43. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema.
Turato G; Zuin R; Miniati M; Baraldo S; Rea F; Beghé B; Monti S; Formichi B; Boschetto P; Harari S; Papi A; Maestrelli P; Fabbri LM; Saetta M
Am J Respir Crit Care Med; 2002 Jul; 166(1):105-10. PubMed ID: 12091179
[TBL] [Abstract][Full Text] [Related]
44. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
[TBL] [Abstract][Full Text] [Related]
45. Innate immunity proteins in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Tsoumakidou M; Bouloukaki I; Thimaki K; Tzanakis N; Siafakas NM
Exp Lung Res; 2010 Aug; 36(6):373-80. PubMed ID: 20653472
[TBL] [Abstract][Full Text] [Related]
46. [Cytochrome C oxidase expression and endothelial cell apoptosis in lungs of patients with chronic obstructive pulmonary disease].
Yang M; Chen P; Peng H; Shen Q; Chen Y
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):665-9. PubMed ID: 21092633
[TBL] [Abstract][Full Text] [Related]
47. Sputum ADAM8 expression is increased in severe asthma and COPD.
Oreo KM; Gibson PG; Simpson JL; Wood LG; McDonald VM; Baines KJ
Clin Exp Allergy; 2014 Mar; 44(3):342-52. PubMed ID: 24147597
[TBL] [Abstract][Full Text] [Related]
48. Cigarette smoke-induced lung inflammation in COPD mediated via CCR1/JAK/STAT /NF-κB pathway.
Zhao K; Dong R; Yu Y; Tu C; Li Y; Cui Y; Bao L; Ling C
Aging (Albany NY); 2020 May; 12(10):9125-9138. PubMed ID: 32463796
[TBL] [Abstract][Full Text] [Related]
49. Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD.
Balbi B; Sangiorgi C; Gnemmi I; Ferrarotti I; Vallese D; Paracchini E; Delle Donne L; Corda L; Baderna P; Corsico A; Carone M; Brun P; Cappello F; Ricciardolo FL; Ruggeri P; Mumby S; Adcock IM; Caramori G; Di Stefano A
Int J Chron Obstruct Pulmon Dis; 2019; 14():1879-1893. PubMed ID: 31686800
[TBL] [Abstract][Full Text] [Related]
50. CXCL13 production in B cells via Toll-like receptor/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary disease.
Litsiou E; Semitekolou M; Galani IE; Morianos I; Tsoutsa A; Kara P; Rontogianni D; Bellenis I; Konstantinou M; Potaris K; Andreakos E; Sideras P; Zakynthinos S; Tsoumakidou M
Am J Respir Crit Care Med; 2013 Jun; 187(11):1194-202. PubMed ID: 23525932
[TBL] [Abstract][Full Text] [Related]
51. Osteoprotegerin in sputum is a potential biomarker in COPD.
To M; Ito K; Ausin PM; Kharitonov SA; Barnes PJ
Chest; 2011 Jul; 140(1):76-83. PubMed ID: 21127170
[TBL] [Abstract][Full Text] [Related]
52. Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers.
Takanashi S; Hasegawa Y; Kanehira Y; Yamamoto K; Fujimoto K; Satoh K; Okamura K
Eur Respir J; 1999 Aug; 14(2):309-14. PubMed ID: 10515406
[TBL] [Abstract][Full Text] [Related]
53. Sputum substance P and neurokinin A are reduced during exacerbations of chronic obstructive pulmonary disease.
Boschetto P; Miotto D; Bononi I; Faggian D; Plebani M; Papi A; Creminon C; De Rosa E; Fabbri LM; Mapp CE
Pulm Pharmacol Ther; 2005; 18(3):199-205. PubMed ID: 15707854
[TBL] [Abstract][Full Text] [Related]
54. Differential activation of killer cells in the circulation and the lung: a study of current smoking status and chronic obstructive pulmonary disease (COPD).
Wang J; Urbanowicz RA; Tighe PJ; Todd I; Corne JM; Fairclough LC
PLoS One; 2013; 8(3):e58556. PubMed ID: 23505535
[TBL] [Abstract][Full Text] [Related]
55. Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD.
Chrysofakis G; Tzanakis N; Kyriakoy D; Tsoumakidou M; Tsiligianni I; Klimathianaki M; Siafakas NM
Chest; 2004 Jan; 125(1):71-6. PubMed ID: 14718423
[TBL] [Abstract][Full Text] [Related]
56. Somatic DNA alterations in lung epithelial barrier cells in COPD patients.
Samara KD; Tzortzaki EG; Neofytou E; Karatzanis AD; Lambiri I; Tzanakis N; Siafakas NM
Pulm Pharmacol Ther; 2010 Jun; 23(3):208-14. PubMed ID: 20040382
[TBL] [Abstract][Full Text] [Related]
57. Similar gene expression profiles in smokers and patients with moderate COPD.
Llinàs L; Peinado VI; Ramon Goñi J; Rabinovich R; Pizarro S; Rodriguez-Roisin R; Barberà JA; Bastos R
Pulm Pharmacol Ther; 2011 Feb; 24(1):32-41. PubMed ID: 20970515
[TBL] [Abstract][Full Text] [Related]
58. Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD.
Kunz LI; Lapperre TS; Snoeck-Stroband JB; Budulac SE; Timens W; van Wijngaarden S; Schrumpf JA; Rabe KF; Postma DS; Sterk PJ; Hiemstra PS;
Respir Res; 2011 Mar; 12(1):34. PubMed ID: 21426578
[TBL] [Abstract][Full Text] [Related]
59. Advanced glycation end products in the skin are enhanced in COPD.
Hoonhorst SJ; Lo Tam Loi AT; Hartman JE; Telenga ED; van den Berge M; Koenderman L; Lammers JW; Boezen HM; Postma DS; Ten Hacken NH
Metabolism; 2014 Sep; 63(9):1149-56. PubMed ID: 25034386
[TBL] [Abstract][Full Text] [Related]
60. Induced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokers.
Singh D; Fox SM; Tal-Singer R; Plumb J; Bates S; Broad P; Riley JH; Celli B;
Thorax; 2011 Jun; 66(6):489-95. PubMed ID: 21441172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
